Emerging molecular technologies for identifying the risk of second cancers
- PMID: 19584072
- PMCID: PMC2733247
- DOI: 10.1158/1940-6207.CAPR-09-0101
Emerging molecular technologies for identifying the risk of second cancers
Conflict of interest statement
The authors disclosed that they have no potential conflicts of interest.
Comment on
-
Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants.Cancer Prev Res (Phila). 2009 Jul;2(7):617-24. doi: 10.1158/1940-6207.CAPR-09-0025. Cancer Prev Res (Phila). 2009. PMID: 19584075 Free PMC article.
References
-
- Travis LB, Rabkin CS, Brown LM, et al. Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst. 2006;98:15–25. - PubMed
-
- Gleich LL, Salamone FN. Molecular genetics of head and neck cancer. Cancer Control. 2002;9:369–78. - PubMed
-
- Khuri FR, Kim ES, Lee JJ, et al. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiology, Biomarkers & Prevention. 2001;10:823–9. - PubMed
-
- Mayne ST, Giovannucci E, Lippman SM. Cancer prevention: Chemoprevention. Retinoids, carotenoids, and other micronutrients in cancer prevention. In: DeVita VT Jr, Lawrence TS, Rosenberg SA, editors. Principles and Practice of Oncology. Philadelphia: Lippincott Williams & Wilkins; 2008. pp. 615–25.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
